We are a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to improve outcomes in patients sufferings
We Interrogate the inner life of GPCR signaling to develop newest therapeutics.
Consetetur sadipscing elitr sediam nonumy eirmod tempoor invidunt labore magna.
Years Experience
Medicament Invented
Awards Winned
Happy Clients
Happy Clients
Balanced mix of new substance developments and life cycle management opportunities.
We focus on core competencies and its many years of experience. We thus hold a leading position in many therapeutic fields: for instance in the treatment of hemophilia and multiple sclerosis, in contrast media and oral contraception. We are also striving for such a leading position in oncology.
Consetetur sadipscing elitr diam nonumy eirmod tempor invidunt.
Ut labore et dolore magna aliquyam erat sed diam voluptua.
Consetetur sadipscing elitr diam nonumy eirmod tempor invidunt.
Ut labore et dolore magna aliquyam erat sed diam voluptua.
Balanced mix of new substance developments and life cycle management opportunities.
We focus on core competencies and its many years of experience. We thus hold a leading position in many therapeutic fields: for instance in the treatment of hemophilia and multiple sclerosis, in contrast media and oral contraception. We are also striving for such a leading position in oncology.
150 Elgin Street — 10th Floor
Ottawa, ON K2P 1L4
Unceded Traditional Algonquin Territory
Tel: 613-730-0687
Fax: 613-730-1196
We look forward to hearing from you.
The AFMC newsletter is published five times per year and brings you all relevant news and information regarding our initiatives and those of our faculties.
By entering your email, you agree to our Terms & Conditions and our Privacy Policy.